01c62b42 Cd67 4a44 8ac9 7daa079ce528 01
Potassium Citrate Tablet, Extended Release
Product Images NDC 65841-536
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Potassium Citrate (NDC 65841-536). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
01c62b42 Cd67 4a44 8ac9 7daa079ce528 02
This is a description of Potassium Citrate Extended-Release Tablets USP, used to treat low potassium levels in the blood. The tablets contain 540mg of Potassium Citrate and are available in packages of 100 tablets with each tablet having a strength of 5mEq. The tablets are debossed with "536" on one side and plain on the other. The package insert should be dispensed with the bottle, and it is recommended to store the medicine at room temperature. The usual dosage and prescribing information are available in the package insert. The product is manufactured by Caia Healthcare Ltd in India.*
01c62b42 Cd67 4a44 8ac9 7daa079ce528 03
Potassium Citrate Extended-release Tablets USP is a medication containing 1080mg of potassium citrate that comes in a tan to yellowish oval- shaped uncoated tablet. It is used to treat kidney stones, and dosage should be taken as per the package insert. The tablets are to be stored in a cool place in a light container and out of children's reach. The medication is manufactured by Cadia Healthcare Ltd in Baddi, India.*
01c62b42 Cd67 4a44 8ac9 7daa079ce528 04
NDC 65841-538-01 - Potassium Citrate Extended-Release Tablets USP (1620 mg per tablet). Each tablet contains 15 mEq (1620 mg) of potassium citrate, USP as monohydrate. The tablets are tan to yellowish color, oblong shaped, biconvex and uncoated. The usual dosage should be seen in the package insert for complete prescribing information. They should be stored at 20° to 25°C (68° to 77°F) in a USP controlled room temperature. These tablets should be dispensed in the exact package without repackaging by the pharmacist. Manufacturer is Cadila Healthcare Ltd., in Baddi, India.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
